PADMA Lax cpr 20 pce

7680358720862 CH-35872 A06AB20 20.03.2.
PADMA Lax cpr 20 pce
PADMA Lax cpr 20 pce
PADMA Lax cpr 20 pce
1 / 3
google

Details

Product number
3587202
CPT
-
Packaging group
20
Unit
Tablette(n)
Composition
aloes extractum siccum normatum (Aloe ferox Mill., Aloe barbadensis Mill., folii succus siccatus) 12.5 mg corresp. glycosida anthrachinoni 2.4-2.6 mg, Auszugsmittel aqua, kaolinum ponderosum 25 mg, calumbae radicis pulvis (Jateorhiza palmata (Lam.) Miers., radix) 10 mg, condurango corticis pulvis (Marsdenia reichenbachii Triana, cortex) 10 mg, helenii rhizomatis pulvis (Inula helenium L., rhizoma) 35 mg, gentianae radicis pulvis (Gentiana lutea L., radix) 35 mg, myrobalani fructus pulvis (Terminalia chebula Retz., fructus) 35 mg, natrii hydrogenocarbonas 15 mg, natrii sulfas anhydricus 35 mg, piperis longi fructus pulvis (Piper longum L.,Piper retrofractum Vahl, fructus) 3.5 mg, frangulae corticis pulvis (Frangula alnus Mill., cortex) 52.5 mg, rhamni purshianae corticis pulvis (Rhamnus purshiana DC., cortex) 52.5 mg, rhei radicis pulvis (Rheum officinale Baill., Rheum palmatum L., radix) 70 mg, strychni seminis pulvis (Strychnos nux-vomica L., semen) 1.75 mg, zingiberis rhizomatis pulvis (Zingiber officinale Roscoe, rhizoma) 70 mg, glucosum liquidum 20 mg, calcii stearas, saccharum 3.8-5.6 mg, pro compresso.

Articles (1)

Padma Lax, Tabletten
Tabletten
20
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Professional SmPC
Allemand
16/11/2023
Professional SmPC
Français
16/11/2023
Professional SmPC
Italien
16/11/2023
Patient information leaflet
Allemand
14/11/2023
Patient information leaflet
Français
14/11/2023
Patient information leaflet
Italien
14/11/2023

Detailed composition

Substance Quantity Type Category
aloes extractum siccum normatum
12.5 MG Substance Wirkstoff (Principe actif)
glycosida anthrachinoni
- Substance WIIS
kaolinum ponderosum
25.0 MG Substance Wirkstoff (Principe actif)
calumbae radicis pulvis
10.0 MG Substance Wirkstoff (Principe actif)
condurango corticis pulvis
10.0 MG Substance Wirkstoff (Principe actif)
helenii rhizomatis pulvis
35.0 MG Substance Wirkstoff (Principe actif)
gentianae radicis pulvis
35.0 MG Substance Wirkstoff (Principe actif)
myrobalani fructus pulvis
35.0 MG Substance Wirkstoff (Principe actif)
natrii hydrogenocarbonas
15.0 MG Substance Wirkstoff (Principe actif)
natrii sulfas anhydricus
35.0 MG Substance Wirkstoff (Principe actif)
piperis longi fructus pulvis
3.5 MG Substance Wirkstoff (Principe actif)
frangulae corticis pulvis
52.5 MG Substance Wirkstoff (Principe actif)
rhamni purshianae corticis pulvis
52.5 MG Substance Wirkstoff (Principe actif)
rhei radicis pulvis
70.0 MG Substance Wirkstoff (Principe actif)
strychni seminis pulvis
1.75 MG Substance Wirkstoff (Principe actif)
zingiberis rhizomatis pulvis
70.0 MG Substance Wirkstoff (Principe actif)
glucosum liquidum
20.0 MG Substance HBESI
calcii stearas
- Substance HNIDK
saccharum
- Substance HBESI

Authorization holder

PADMA AG

8620 Wetzikon ZH

Authorization information

Swissmedic authorization number
35872
Drug name
Padma Lax, Tabletten
Galenic form
TAB
ATC Code
A06AB20
Authorization status
Z
Dispensation category
B/D
First authorization
17/11/1970
Authorization expiration date
31/12/9999
IT number
20.03.2.
Domain
Human medicine
Field of application
Nach den Therapieprinzipien der Tibetischen Medizin bei Verstopfung

Packaging details

Description (FR)
PADMA Lax cpr 20 pce
Description (DE)
PADMA Lax Tabl 20 Stk
Market launch
30/10/1996
Narcotic (BTM)
No

Other packaging sizes

PADMA Lax cpr 60 pce
60 TABL
View
Buy us a coffee Explore the data